The 4th Rare Cancers Symposium, hosted by TRACER at Fred Hutch in Seattle, brought together leading researchers, clinicians and advocates to share progress in immunotherapy, biobanking, and clinical trial design for rare cancers. From patient-driven initiatives to cutting-edge diagnostics, the event underscored the power of collaboration in tackling rare diseases.
Read the full story here: